Keyphrases
Heart Failure
51%
Patients with Heart Failure
47%
Chronic Heart Failure
32%
Heart Failure with Preserved Ejection Fraction (HFpEF)
25%
Biology Study
23%
Tailored Treatment
23%
Worsening Heart Failure
21%
BIOSTAT-CHF
20%
All-cause Mortality
20%
Confidence Interval
19%
Hazard Ratio
15%
Heart Failure Hospitalization
13%
New-onset Heart Failure
13%
Pathophysiological Pathways
12%
Heart Failure Patients
12%
Up-titration
9%
Medical Therapy
8%
Angiotensin-converting Enzyme Inhibitor (ACEi)
8%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
8%
Mitral Regurgitation
8%
Carbohydrates
8%
Clinical Outcomes
7%
Left Ventricular Ejection Fraction
7%
Acute Heart Failure
6%
Angiotensin Receptor Blockers
6%
Quality of Life
6%
Clinical Characteristics
5%
Atrial Fibrillation
5%
Congestion
5%
Heart Failure Severity
5%
Whole Blood
5%
Kansas City Cardiomyopathy Questionnaire
5%
Beta-blockers
5%
Cardiovascular Mortality
5%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Heart Failure with Reduced Ejection Fraction
14%
All Cause Mortality
13%
Biological Marker
12%
Pathophysiology
9%
Combination Therapy
8%
Mitral Valve Regurgitation
8%
Disease Severity
8%
Dipeptidyl Carboxypeptidase Inhibitor
7%
Angiotensin Receptor Antagonist
7%
Inflammation
7%
Acute Heart Failure
5%
Heart Failure with Preserved Ejection Fraction
5%
Myocardial Disease
5%
Medicine and Dentistry
Congestive Heart Failure
73%
Heart Failure with Reduced Ejection Fraction
13%
Biological Marker
10%
Combination Therapy
8%
Mitral Insufficiency
8%
Hazard Ratio
7%
Titrimetry
7%
Heart Left Ventricle Ejection Fraction
6%
Ejection Fraction
6%
Pathophysiology
6%
Serositis
5%
Acute Decompensated Heart Failure
5%
Neutrophil
5%
ACE Inhibitor
5%
Angiotensin Receptor Antagonist
5%
Proteomics
5%
Heart Failure with Preserved Ejection Fraction
5%